| UniProt ID | SEPT1_HUMAN | |
|---|---|---|
| UniProt AC | Q8WYJ6 | |
| Protein Name | Septin-1 | |
| Gene Name | 1-Sep | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 367 | |
| Subcellular Localization | Cytoplasm. Cytoplasm, cytoskeleton. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Midbody. Remains at the centrosomes and the nearby microtubules throughout mitosis. Localizes to the midbody during cytokinesis. | |
| Protein Description | Filament-forming cytoskeletal GTPase (By similarity). May play a role in cytokinesis (Potential).. | |
| Protein Sequence | MDKEYVGFAALPNQLHRKSVKKGFDFTLMVAGESGLGKSTLINSLFLTNLYEDRQVPEASARLTQTLAIERRGVEIEEGGVKVKLTLVDTPGFGDSVDCSDCWLPVVKFIEEQFEQYLRDESGLNRKNIQDSRVHCCLYFISPFGRGLRPLDVAFLRAVHEKVNIIPVIGKADALMPQETQALKQKIRDQLKEEEIHIYQFPECDSDEDEDFKRQDAEMKESIPFAVVGSCEVVRDGGNRPVRGRRYSWGTVEVENPHHCDFLNLRRMLVQTHLQDLKEVTHDLLYEGYRARCLQSLARPGARDRASRSKLSRQSATEIPLPMLPLADTEKLIREKDEELRRMQEMLEKMQAQMQQSQAQGEQSDAL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Ubiquitination | -----MDKEYVGFAA -----CCHHHCCEEC | 50.04 | - | |
| 5 | Phosphorylation | ---MDKEYVGFAALP ---CCHHHCCEECCC | 16.18 | 30576142 | |
| 19 | Phosphorylation | PNQLHRKSVKKGFDF CCHHHHHHHHCCCCE | 38.84 | - | |
| 22 | Ubiquitination | LHRKSVKKGFDFTLM HHHHHHHCCCCEEEE | 63.76 | - | |
| 44 | Phosphorylation | GKSTLINSLFLTNLY CHHHHHHHHHHCCCC | 17.32 | 30631047 | |
| 48 | Phosphorylation | LINSLFLTNLYEDRQ HHHHHHHCCCCCCCC | 18.82 | - | |
| 51 | Phosphorylation | SLFLTNLYEDRQVPE HHHHCCCCCCCCCCH | 20.18 | 28674151 | |
| 60 | Phosphorylation | DRQVPEASARLTQTL CCCCCHHHHHHHHHH | 16.56 | - | |
| 65 | Ubiquitination | EASARLTQTLAIERR HHHHHHHHHHHHHHC | 38.82 | - | |
| 69 | Ubiquitination | RLTQTLAIERRGVEI HHHHHHHHHHCCEEE | 4.81 | - | |
| 82 | Ubiquitination | EIEEGGVKVKLTLVD EEEECCEEEEEEEEC | 36.61 | - | |
| 84 | Ubiquitination | EEGGVKVKLTLVDTP EECCEEEEEEEECCC | 30.00 | - | |
| 129 | Ubiquitination | SGLNRKNIQDSRVHC CCCCCCCCCCCCHHH | 5.59 | - | |
| 131 | Ubiquitination | LNRKNIQDSRVHCCL CCCCCCCCCCHHHHH | 34.31 | - | |
| 132 | Phosphorylation | NRKNIQDSRVHCCLY CCCCCCCCCHHHHHH | 21.59 | - | |
| 162 | Acetylation | FLRAVHEKVNIIPVI HHHHHHHHCCEEEEE | 26.21 | 25953088 | |
| 162 | Ubiquitination | FLRAVHEKVNIIPVI HHHHHHHHCCEEEEE | 26.21 | - | |
| 171 | Ubiquitination | NIIPVIGKADALMPQ CEEEEECCHHHCCHH | 31.78 | - | |
| 174 | Ubiquitination | PVIGKADALMPQETQ EEECCHHHCCHHHHH | 15.60 | - | |
| 176 | Sulfoxidation | IGKADALMPQETQAL ECCHHHCCHHHHHHH | 3.27 | 21406390 | |
| 184 | Ubiquitination | PQETQALKQKIRDQL HHHHHHHHHHHHHHH | 53.19 | - | |
| 186 | Ubiquitination | ETQALKQKIRDQLKE HHHHHHHHHHHHHHH | 37.81 | - | |
| 199 | Phosphorylation | KEEEIHIYQFPECDS HHCCEEEEECCCCCC | 7.02 | 30576142 | |
| 206 | Phosphorylation | YQFPECDSDEDEDFK EECCCCCCCCCCCHH | 55.34 | 20058876 | |
| 209 | Ubiquitination | PECDSDEDEDFKRQD CCCCCCCCCCHHHHC | 66.80 | - | |
| 211 | Phosphorylation | CDSDEDEDFKRQDAE CCCCCCCCHHHHCHH | 67.69 | 24275569 | |
| 218 | Ubiquitination | DFKRQDAEMKESIPF CHHHHCHHHHHHCCE | 60.11 | - | |
| 220 | Ubiquitination | KRQDAEMKESIPFAV HHHCHHHHHHCCEEE | 39.55 | - | |
| 222 | Phosphorylation | QDAEMKESIPFAVVG HCHHHHHHCCEEEEE | 30.00 | 26074081 | |
| 231 | Ubiquitination | PFAVVGSCEVVRDGG CEEEEECEEEEECCC | 3.65 | - | |
| 233 | Ubiquitination | AVVGSCEVVRDGGNR EEEECEEEEECCCCC | 5.12 | - | |
| 240 | Methylation | VVRDGGNRPVRGRRY EEECCCCCCCCCCEE | 34.07 | 115387871 | |
| 246 | Phosphorylation | NRPVRGRRYSWGTVE CCCCCCCEEECEEEE | 32.44 | - | |
| 247 | Phosphorylation | RPVRGRRYSWGTVEV CCCCCCEEECEEEEE | 13.86 | 26657352 | |
| 248 | Phosphorylation | PVRGRRYSWGTVEVE CCCCCEEECEEEEEC | 19.74 | 23401153 | |
| 251 | Phosphorylation | GRRYSWGTVEVENPH CCEEECEEEEECCCC | 13.77 | 28122231 | |
| 253 | Phosphorylation | RYSWGTVEVENPHHC EEECEEEEECCCCCC | 43.91 | 19690332 | |
| 256 | Phosphorylation | WGTVEVENPHHCDFL CEEEEECCCCCCCHH | 46.51 | - | |
| 260 | Ubiquitination | EVENPHHCDFLNLRR EECCCCCCCHHHHHH | 3.44 | - | |
| 267 | Ubiquitination | CDFLNLRRMLVQTHL CCHHHHHHHHHHHHH | 26.42 | - | |
| 278 | Ubiquitination | QTHLQDLKEVTHDLL HHHHHHHHHHHHHHH | 59.43 | - | |
| 286 | Phosphorylation | EVTHDLLYEGYRARC HHHHHHHHHHHHHHH | 18.01 | 28796482 | |
| 287 | Methylation | VTHDLLYEGYRARCL HHHHHHHHHHHHHHH | 50.12 | - | |
| 289 | Phosphorylation | HDLLYEGYRARCLQS HHHHHHHHHHHHHHH | 6.80 | 29978859 | |
| 294 | Phosphorylation | EGYRARCLQSLARPG HHHHHHHHHHHCCCC | 3.02 | 27251275 | |
| 295 | Phosphorylation | GYRARCLQSLARPGA HHHHHHHHHHCCCCC | 39.77 | 20058876 | |
| 298 | Phosphorylation | ARCLQSLARPGARDR HHHHHHHCCCCCHHH | 22.37 | - | |
| 307 | Phosphorylation | PGARDRASRSKLSRQ CCCHHHHHHHHHCCC | 37.67 | 26074081 | |
| 309 | Phosphorylation | ARDRASRSKLSRQSA CHHHHHHHHHCCCCC | 35.14 | 29978859 | |
| 312 | Phosphorylation | RASRSKLSRQSATEI HHHHHHHCCCCCCCC | 31.82 | 23401153 | |
| 315 | Phosphorylation | RSKLSRQSATEIPLP HHHHCCCCCCCCCCC | 35.73 | 20164059 | |
| 317 | Phosphorylation | KLSRQSATEIPLPML HHCCCCCCCCCCCCC | 39.43 | 28787133 | |
| 320 | Phosphorylation | RQSATEIPLPMLPLA CCCCCCCCCCCCCCC | 24.95 | 16179162 | |
| 325 | Ubiquitination | EIPLPMLPLADTEKL CCCCCCCCCCCHHHH | 21.17 | - | |
| 329 | Phosphorylation | PMLPLADTEKLIREK CCCCCCCHHHHHHHH | 29.43 | 26074081 | |
| 331 | Ubiquitination | LPLADTEKLIREKDE CCCCCHHHHHHHHHH | 51.84 | - | |
| 349 | Ubiquitination | RMQEMLEKMQAQMQQ HHHHHHHHHHHHHHH | 32.14 | - | |
| 354 | Phosphorylation | LEKMQAQMQQSQAQG HHHHHHHHHHHHHHH | 4.37 | 16179162 | |
| 357 | Phosphorylation | MQAQMQQSQAQGEQS HHHHHHHHHHHHHHC | 15.59 | 28111955 | |
| 362 | Phosphorylation | QQSQAQGEQSDAL-- HHHHHHHHHCCCC-- | 34.53 | 16179162 | |
| 364 | Phosphorylation | SQAQGEQSDAL---- HHHHHHHCCCC---- | 22.13 | 30576142 | |
| 378 | Ubiquitination | ------------------ ------------------ | - | ||
| 383 | Ubiquitination | ----------------------- ----------------------- | - | ||
| 396 | Ubiquitination | ------------------------------------ ------------------------------------ | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SEPT1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SEPT1_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-248 AND SER-315, ANDMASS SPECTROMETRY. | |
| "Septin1, a new interaction partner for human serine/threonine kinaseaurora-B."; Qi M., Yu W., Liu S., Jia H., Tang L., Shen M., Yan X., Saiyin H.,Lang Q., Wan B., Zhao S., Yu L.; Biochem. Biophys. Res. Commun. 336:994-1000(2005). Cited for: SUBCELLULAR LOCATION, INTERACTION WITH AURKB, PHOSPHORYLATION ATSER-248; SER-307 AND SER-315, AND MUTAGENESIS OF SER-19; SER-206;SER-248; SER-307; SER-312 AND SER-315. | |